The yearly MEET2WIN partnering convention is attended by an ever-evolving audience of over 300 European life sciences oncology R&D companies across biotech, medtech, digital health and AI, along with investors, big pharma, academics, clusters, institutional attendees, and a broad range of valued service providers.
During two days (May 6 & 7), this 2025 edition will address the major scientific advances in cancer research over the last ten years, the challenges to funding and support to rapidly transform these discoveries into useful innovations for patients:
